Trials / Completed
CompletedNCT00209924
A Study of Gaboxadol in Primary Insomnia
A Prospective Randomised Double-Blind Parallel-Group Placebo-Controlled Study of Gaboxadol in Primary Insomnia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 505 (planned)
- Sponsor
- H. Lundbeck A/S · Industry
- Sex
- All
- Age
- 66 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy safety and tolerability of gaboxadol in primary insomnia.
Detailed description
To compare hypnotic efficacy of gaboxadol with placebo in elderly outpatients with primary insomnia
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Gaboxadol |
Timeline
- Start date
- 2004-04-01
- Completion
- 2005-11-01
- First posted
- 2005-09-21
- Last updated
- 2007-03-30
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT00209924. Inclusion in this directory is not an endorsement.